{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:05:47Z","timestamp":1790629547913,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL161141"],"award-info":[{"award-number":["R01HL161141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009109","name":"Bayer Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016888","name":"Bayer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajt.2026.09.013","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:19:57Z","timestamp":1789453197000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanomedicine in lung transplantation: Emerging solutions for clinical challenges"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8745-1960","authenticated-orcid":false,"given":"Andreas","family":"Maskos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-6674","authenticated-orcid":false,"given":"Aravind","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-7614","authenticated-orcid":false,"given":"Matthew M.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-3056","authenticated-orcid":false,"given":"Edgar","family":"Aranda-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0061-1584","authenticated-orcid":false,"given":"Elbert E.","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6492-3180","authenticated-orcid":false,"given":"Alex","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6737-3380","authenticated-orcid":false,"given":"Daniel","family":"Alnasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8727-4540","authenticated-orcid":false,"given":"Jonas","family":"Hildinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-3092","authenticated-orcid":false,"given":"Jasper","family":"Iske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-860X","authenticated-orcid":false,"given":"Sebastian","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-9110","authenticated-orcid":false,"given":"Mahdi","family":"Forouharshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9473-7422","authenticated-orcid":false,"given":"Mark R.","family":"Nicolls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-7429","authenticated-orcid":false,"given":"Kunal S.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-4216","authenticated-orcid":false,"given":"John W.","family":"MacArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ajt.2026.09.013_bib1","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMra2401039","article-title":"Lung transplantation","volume":"391","author":"Christie","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ajt.2026.09.013_bib2","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.21037\/jtd.2017.07.85","article-title":"Outcomes after lung transplantation","volume":"9","author":"Thabut","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ajt.2026.09.013_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.21037\/ccts-20-174","article-title":"Chronic and long-term complications after lung transplant: a narrative review","volume":"5","author":"Erasmus","year":"2023","journal-title":"Curr Chall Thorac Surg"},{"issue":"suppl 1","key":"10.1016\/j.ajt.2026.09.013_bib4","article-title":"Improvement in wait list mortality for the most critically ill since the implementation of the CAS","volume":"211","author":"Raddawi","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s11948-015-9705-6","article-title":"Defining nano, nanotechnology and nanomedicine: why should it matter?","volume":"22","author":"Satalkar","year":"2016","journal-title":"Sci Eng Ethics"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41565-024-01786-z","article-title":"Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium","volume":"20","author":"Nayak","year":"2025","journal-title":"Nat Nanotechnol"},{"issue":"10","key":"10.1016\/j.ajt.2026.09.013_bib7","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1111\/ajt.13907","article-title":"Noninvasive imaging of CCR2+ cells in ischemia-reperfusion injury after lung transplantation","volume":"16","author":"Liu","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.09.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214558","article-title":"Inhalation metal-phenolic nanozyme as a novel therapeutic strategy for lung ischemia-reperfusion injury","volume":"180","author":"Sun","year":"2026","journal-title":"Biomater Adv"},{"key":"10.1016\/j.ajt.2026.09.013_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1176369","article-title":"Near-infrared laser-irradiated upconversion nanoparticles with dexamethasone precise released for alleviating lung ischemia-reperfusion injury","volume":"11","author":"He","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"10.1016\/j.ajt.2026.09.013_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.nano.2012.02.017","article-title":"Tracking T-cells in vivo with a new nano-sized MRI contrast agent","volume":"8","author":"Liu","year":"2012","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nnm.13.208","article-title":"Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction","volume":"10","author":"Cova","year":"2015","journal-title":"Nanomedicine (Lond)"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/17435390.2017.1317862","article-title":"Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents","volume":"11","author":"Cova","year":"2017","journal-title":"Nanotoxicology"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77828-y","article-title":"Loading imatinib inside targeted nanoparticles to prevent bronchiolitis obliterans Syndrome","volume":"10","author":"Pandolfi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajt.2026.09.013_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2014.08.020","article-title":"Enhanced gene delivery in porcine vasculature tissue following incorporation of adeno-associated virus nanoparticles into porous silicon microparticles","volume":"194","author":"McConnell","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.ajt.2026.09.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2026.06.011","article-title":"Intraorgan and targeted nanodelivery in organ transplantation of nonhuman primates","author":"Jung","year":"2026","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2026.09.013_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/ijms19082310","article-title":"Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus","volume":"19","author":"Chiesa","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/acsabm.5c01686","article-title":"Stimuli-responsive polymeric conjugates of tacrolimus: a pH\/redox-triggered approach toward precision drug delivery","volume":"9","author":"Sharma","year":"2026","journal-title":"ACS Appl Bio Mater"},{"issue":"9","key":"10.1016\/j.ajt.2026.09.013_bib18","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/cells10092249","article-title":"Perfluorocarbon-based oxygen carriers and subnormothermic lung machine perfusion decrease production of pro-inflammatory mediators","volume":"10","author":"Arni","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ajt.2026.09.013_bib19","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3390\/cells9112501","article-title":"Functional, metabolic and morphologic results of ex vivo donor lung perfusion with a perfluorocarbon-based oxygen carrier nanoemulsion in a large animal transplantation model","volume":"9","author":"Inci","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ejpb.2008.01.037","article-title":"Nebulization of nanoparticulate amorphous or crystalline tacrolimus \u2013 single-dose pharmacokinetics study in mice","volume":"69","author":"Sinswat","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.ajt.2026.09.013_bib21","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.jtcvs.2017.07.083","article-title":"The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model","volume":"154","author":"Das","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.ajt.2026.09.013_bib22","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3390\/pharmaceutics15102372","article-title":"A reversibly thermoresponsive, theranostic nanoemulgel for tacrolimus delivery to activated macrophages: formulation and in vitro validation","volume":"15","author":"Vichare","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ajt.2026.09.013_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2026.03.007","article-title":"Multi-center open-label tacrolimus inhalation powder trial evaluating safety, tolerability, efficacy, and pharmacokinetics in adult lung transplant recipients with significant renal impairment","volume":"45","author":"Snell","year":"2026","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41565-021-00997-y","article-title":"Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation","volume":"17","author":"Myerson","year":"2022","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/TP.0b013e318226bc6b","article-title":"Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death","volume":"92","author":"Preissler","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejpb.2010.12.013","article-title":"Surfactant protein A (SP-A)-tacrolimus complexes have a greater anti-inflammatory effect than either SP-A or tacrolimus alone on human macrophage-like U937 cells","volume":"77","author":"L\u00f3pez-S\u00e1nchez","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.ajt.2026.09.013_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biomaterials.2013.09.092","article-title":"Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib28","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.jtcvs.2022.10.022","article-title":"Reduction of donor mononuclear phagocytes with clodronate-liposome during ex vivo lung perfusion attenuates ischemia-reperfusion injury","volume":"165","author":"Yamanashi","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.ajt.2026.09.013_bib29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ajt.2024.03.028","article-title":"Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury","volume":"24","author":"Liao","year":"2024","journal-title":"Am J Transplant"},{"issue":"14","key":"10.1016\/j.ajt.2026.09.013_bib30","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.3390\/ijms22147743","article-title":"Liposomes loaded with everolimus and coated with hyaluronic acid: a promising approach for lung fibrosis","volume":"22","author":"Pandolfi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajt.2026.09.013_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpb.2021.11.011","article-title":"Bioinspired carbon monoxide delivery using artificial blood attenuates the progression of obliterative bronchiolitis via suppression of macrophage activation by IL-17A","volume":"170","author":"Watabe","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib32","doi-asserted-by":"crossref","first-page":"00167","DOI":"10.1183\/23120541.00167-2019","article-title":"A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation","volume":"5","author":"Iacono","year":"2019","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajt.16858","article-title":"A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation","volume":"22","author":"Neurohr","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2026.09.013_bib34","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.942823","volume":"29","author":"Iacono","year":"2024","journal-title":"Ann Transplant"},{"key":"10.1016\/j.ajt.2026.09.013_bib35","article-title":"Impact of lung function decline on mortality in lung transplant recipients: long-term results from the L-CsA-i study for the prevention of bronchiolitis obliterans syndrome","volume":"9","author":"Kneidinger","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajt.2026.09.013_bib37","unstructured":"Efficacy + safety of liposome cyclosporine A to treat bronchiolitis obliterans post double lung transplant (BOSTON-2). ClinicalTrials.gov identifier: NCT03656926. Updated February 2, 2026. Accessed July 9, 2026. https:\/\/clinicaltrials.gov\/study\/NCT03656926."},{"key":"10.1016\/j.ajt.2026.09.013_bib38","unstructured":"Extension trial on efficacy\/safety of L-CsA + SoC in treating BOS in post single or double lung transplant (BOSTON-3). ClinicalTrials.gov identifier: NCT04039347. Updated April 7, 2026. Accessed July 9, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04039347."},{"issue":"6","key":"10.1016\/j.ajt.2026.09.013_bib39","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/pharmaceutics18060684","article-title":"CaP-coated cyclosporine A liposomes formulated as an inhalable dry powder for lung inflammatory diseases","volume":"18","author":"D\u2019Angelo","year":"2026","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib40","first-page":"675","article-title":"Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics","volume":"2","author":"Chougule","year":"2007","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jtcvs.2025.10.021","article-title":"Safety risks of intratracheal lipid nanoparticle gene delivery to the lung and potential mitigation strategies","volume":"171","author":"Nagoya","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"14","key":"10.1016\/j.ajt.2026.09.013_bib42","doi-asserted-by":"crossref","first-page":"13790","DOI":"10.1021\/acsnano.4c16617","article-title":"Lipid nanoparticles for in vivo lung delivery of CRISPR-Cas9 ribonucleoproteins allow gene editing of clinical targets","volume":"19","author":"Haley","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajt.2026.09.013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2026.05.2303","article-title":"Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation","author":"Mineura","year":"2026","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtcvs.2025.03.012","article-title":"Extracellular vesicles in lung donor plasma: potential indicators of donor organ quality","volume":"170","author":"Joo","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.ajt.2026.09.013_bib45","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.healun.2019.08.016","article-title":"Mesenchymal stem cell\u2013derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia\/reperfusion injury","volume":"38","author":"Lonati","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12931-017-0704-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death","volume":"18","author":"Stone","year":"2017","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.ajt.2026.09.013_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.healun.2025.03.018","article-title":"Preconditioning donor lungs with lung-derived exosomes mitigates ischemia-reperfusion injury in a warm ischemia porcine DCD model","volume":"44","author":"Ribeiro","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"42","key":"10.1016\/j.ajt.2026.09.013_bib48","article-title":"Engineering neutrophil vesicles for synergistic protection against ischemia\/reperfusion injury after lung transplant","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajt.2026.09.013_bib49","first-page":"319","article-title":"Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia\u2013reperfusion lung injury and pneumonia","volume":"62","author":"Yuan","year":"2026","journal-title":"Bioact Mater"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/TP.0000000000003820","article-title":"Circulating donor lung-specific exosome profiles enable noninvasive monitoring of acute rejection in a rodent orthotopic lung transplantation model","volume":"106","author":"Habertheuer","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2026.09.013_bib51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.xjtc.2025.03.005","article-title":"B-cell extracellular vesicle biomarkers for detection of antibody-mediated rejection in lung transplantation","volume":"31","author":"Korutla","year":"2025","journal-title":"JTCVS Tech"},{"issue":"9","key":"10.1016\/j.ajt.2026.09.013_bib52","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ajt.2026.04.021","article-title":"Circulating T cell-specific extracellular vesicles as biomarkers of acute cellular rejection after lung transplantation","volume":"26","author":"Korutla","year":"2026","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib53","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/TP.0000000000005175","article-title":"Circulating vesicular-bound HLA-G as noninvasive predictive biomarker of CLAD after lung transplantation","volume":"109","author":"Brugi\u00e8re","year":"2025","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70298","article-title":"MiR-146a engineered extracellular vesicles derived from mesenchymal stromal cells more potently attenuate ischaemia\u2013reperfusion injury in lung transplantation","volume":"15","author":"Yang","year":"2025","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ajt.2026.09.013_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2019.01.022","article-title":"Mesenchymal stromal cells-derived exosomes alleviate ischemia\/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p","volume":"852","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajt.2026.09.013_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111440","article-title":"Bone marrow mesenchymal stem cells-derived exosomal miR-381 alleviates lung ischemia-reperfusion injury by activating Treg differentiation through inhibiting YTHDF1 expression","volume":"124","author":"Gao","year":"2024","journal-title":"Cell Signal"},{"issue":"9","key":"10.1016\/j.ajt.2026.09.013_bib57","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/jimmun\/vkaf097","article-title":"miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury","volume":"214","author":"Yang","year":"2025","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2026.09.013_bib58","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.healun.2020.09.012","article-title":"MicroRNA-206 antagomiR\u2012enriched extracellular vesicles attenuate lung ischemia\u2012reperfusion injury through CXCL1 regulation in alveolar epithelial cells","volume":"39","author":"Cai","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib59","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s12035-022-03129-2","article-title":"BMSC-derived exosomes carrying lncRNA-ZFAS1 alleviate pulmonary ischemia\/reperfusion injury by UPF1-mediated mRNA decay of FOXD1","volume":"60","author":"Gao","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.ajt.2026.09.013_bib60","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/JS9.0000000000002217","article-title":"SNHG16 alleviates pulmonary ischemia-reperfusion injury by promoting the Warburg effect through regulating MTCH2 expression: experimental studies","volume":"111","author":"Zhou","year":"2025","journal-title":"Int J Surg"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib61","article-title":"Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury","volume":"7","author":"Yuan","year":"2026","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib62","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.healun.2024.02.290","article-title":"An in vitro study of virus-like particle mediated CRISPR gene editing to support gene modulation in the human ex vivo lung","volume":"43","author":"Kortleven","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"15-16","key":"10.1016\/j.ajt.2026.09.013_bib63","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/hum.2024.258","article-title":"Trojan horse-like vehicles for CRISPR-Cas delivery: engineering extracellular vesicles and virus-like particles for precision gene editing in cystic fibrosis","volume":"36","author":"Dipalo","year":"2025","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajt.2026.09.013_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.xjon.2025.01.008","article-title":"Application of a degradable thin film to modulate perfusion to post-autotransplantation airways in rats","volume":"24","author":"Krishnan","year":"2025","journal-title":"JTCVS Open"},{"key":"10.1016\/j.ajt.2026.09.013_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.152469","article-title":"Chitosan nanoparticles-incorporated polylactic acid\/tacrolimus nanofiber composite membrane for tracheal scar inhibition and tracheal wound healing promotion","volume":"366","author":"Lv","year":"2026","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10.1016\/j.ajt.2026.09.013_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/pharmaceutics14020302","article-title":"Strategies to overcome biological barriers associated with pulmonary drug delivery","volume":"14","author":"Plaunt","year":"2022","journal-title":"Pharmaceutics"},{"issue":"suppl 2","key":"10.1016\/j.ajt.2026.09.013_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000445116","article-title":"Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications","volume":"25","author":"Rudokas","year":"2016","journal-title":"Med Princ Pract"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/pharmaceutics17030389","article-title":"Nanotechnology-based therapies for preventing post-surgical adhesions","volume":"17","author":"Teo","year":"2025","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ajt.2026.09.013_bib69","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.1021\/acsnano.1c04707","article-title":"Intra-organ delivery of nanotherapeutics for organ transplantation","volume":"15","author":"Hussain","year":"2021","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib70","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOT.0b013e32833deca9","article-title":"Bronchial blood supply after lung transplantation without bronchial artery revascularization","volume":"15","author":"Nicolls","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.09.013_bib71","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.200910-1573OC","article-title":"Lung transplant airway hypoxia: a diathesis to fibrosis?","volume":"182","author":"Dhillon","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib72","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1164\/rccm.200207-670SO","article-title":"Ischemia\u2013reperfusion\u2013induced lung injury","volume":"167","author":"de Perrot","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib73","doi-asserted-by":"crossref","first-page":"H1283","DOI":"10.1152\/ajpheart.00251.2010","article-title":"Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process","volume":"299","author":"den","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajt.2026.09.013_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2025.102326","article-title":"Characteristics linking ischemia-reperfusion to chronic lung allograft dysfunction in lung transplantation: a single-cell bioinformatics analysis","volume":"93","author":"Zhang","year":"2025","journal-title":"Transpl Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2026.09.013_bib75","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/ajt.16784","article-title":"The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury","volume":"21","author":"Iske","year":"2021","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib76","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ejcts\/ezt489","article-title":"The depletion of donor macrophages reduces ischaemia-reperfusion injury after mouse lung transplantation","volume":"45","author":"Tsushima","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"10.1016\/j.ajt.2026.09.013_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70042","article-title":"Extracellular vesicles in lung transplantation: biomarkers, pathophysiological players, and therapeutic weapons?","volume":"55","author":"Mandin","year":"2025","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib78","doi-asserted-by":"crossref","first-page":"00675","DOI":"10.1183\/23120541.00675-2024","article-title":"Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres","volume":"11","author":"Gottlieb","year":"2025","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.013_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chest.2018.08.1036","article-title":"The future of lung transplantation","volume":"155","author":"Young","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.ajt.2026.09.013_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931251","article-title":"Novel approaches for long-term lung transplant survival","volume":"13","author":"Miller","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib81","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.healun.2024.01.016","article-title":"Creating superior lungs for transplantation with next-generation gene therapy during ex vivo lung perfusion","volume":"43","author":"Nyk\u00e4nen","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.013_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000266","article-title":"Functional repair of human donor lungs by IL-10 gene therapy","volume":"1","author":"Cypel","year":"2009","journal-title":"Sci Transl Med"},{"issue":"1-2","key":"10.1016\/j.ajt.2026.09.013_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hum.2019.220","article-title":"Can adeno-associated viral vectors deliver effectively large genes?","volume":"31","author":"Tornabene","year":"2020","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.013_bib84","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/j.ajt.2026.09.013_bib85","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nbt.1696","article-title":"Rapid translocation of nanoparticles from the lung airspaces to the body","volume":"28","author":"Choi","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"26","key":"10.1016\/j.ajt.2026.09.013_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv Mater"},{"issue":"6","key":"10.1016\/j.ajt.2026.09.013_bib87","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2217\/nnm.13.49","article-title":"Nanoparticles and the blood coagulation system. Part II: safety concerns","volume":"8","author":"Ilinskaya","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ajt.2026.09.013_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603039","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2026.09.013_bib89","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the gap: the role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems","volume":"20","author":"Herdiana","year":"2025","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.013_bib90","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","article-title":"The challenges of oral drug delivery via nanocarriers","volume":"25","author":"Reinholz","year":"2018","journal-title":"Drug Deliv"},{"issue":"8","key":"10.1016\/j.ajt.2026.09.013_bib91","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph17081059","article-title":"Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine","volume":"17","author":"Cojocaru","year":"2024","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:30:43Z","timestamp":1790627443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526027565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":90,"alternative-id":["S1600613526027565"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.09.013","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine in lung transplantation: Emerging solutions for clinical challenges","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}